The mission of the NCIís Office of Cancer Genomics (OCG) is to enhance the understanding of the molecular mechanisms of cancer, advance and accelerate genomics science and technology development, and efficiently translate the genomics data to improve cancer prevention, early detection, diagnosis and treatment.
The primary goals of the OCG are to:
- Provide information, technology, methods, informatics tools, and reagents to serve the needs of the cancer research community.
- Support, lead, manage, maintain and/or impact upon seven major research programs, both currently and previously run out of OCG:
- Cancer Genome Anatomy Project (CGAP)/Cancer Genome Characterization Initiative (CGCI)
- Cancer Target Discovery and Development (CTD²) Network
- Therapeutically Applicable Research to Generate Effective Treatments (TARGET)
- Initiative for Chemical Genetics (ICG)
- NIH Mammalian Gene Collection (MGC)
- Cancer Genetic Markers of Susceptibility (CGEMS)
- The Cancer Genome Atlas (TCGA)
- Establish and maintain relationships with advisory groups for each of the above programs.